• Adab N, Jacoby A, Smith D, Chadwick D. (2001) Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70:1521.
  • Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW. (2004a) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75:15751583.
  • Adab N, Tudur SC, Vinten J, Williamson P, Winterbottom J. (2004b) Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev 3:CD004848.
  • Banach R, Boskovic R, Einarson T, Koren G. (2010) Long-term developmental outcome of children to women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs- a meta-analysis of cohort studies. Drug Saf 33:7379.
  • Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, Dzietko M, Pesditschek S, Mai I, Dikranian K, Olney JW, Ikonomidou C. (2002) Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 99:1508915094.
  • Eriksson K, Viinikainen K, Mönkkönen A, Äikiä M, Nieminen P, Heinonen S, Kälviäinen R. (2005) Children exposed to valproate in utero- population based evaluation of risks and confounding factors for long-term neurodevelopment. Epilepsy Res 65:189200.
  • Gaily E, Kantola-Sorsa E, Hiilesmaa V, Isoaho M, Matila R, Kotila M, Nylund T, Bardy A, Kaaja E, Granström M-L. (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62:2832.
  • Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes B, Krumholz A, Finnell R, Hirtz D, Le Guen C. (2009) Management issues for women with epilepsy - focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes. Epilepsia 50: 12371246.
  • Källén AJB. (1994) Maternal carbamazepine and infant spina bifida. Reprod Toxicol 8:203205.
  • Kini U, Adab N, Vinten J, Fryer A, Clayton-Smith J. (2006) Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 91:F90F95.
  • Koch S, Titze K, Zimmermann RB, Schröder M, Lehmkuhl U, Rauh H. (1999) Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 40:12371243.
  • Lösche G, Steinhausen HC, Koch S, Helge H. (1994) The psychological development for children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors. Acta Paediatr 83:961966.
  • Meador KJ, Pennell PB, Harden CL, Gordon JC, Tomson T, Kaplan PW, Holmes GL, French JA, Hauser WA, Wells PG, Cramer JA, HOPE workgroup. (2008) Pregnancy registries in epilepsy: a consensus statement on health outcomes. Neurology 71:11091117.
  • Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW, NEAD Study Group. (2009) Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360:15971605.
  • Moore SJ, Turnpenny P, Quinn A. (2000) A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 37:489497.
  • National Agency for Education (2004) Education results – national level. Available at: .
  • National Board of Health and Welfare, Centre for Epidemiology (2003) The Swedish Medical Birth Registry – a summary of content and quality. Available at: 2003/2003-112-3.
  • Samrén EB, van Duijn CM, Koch S, Hiilesmaa VK, Klepel H, Bardy AH, Beck Mannagetta SG, Deichl AW, Gaily E, Granstrom ML, Meinardi H, Grobbee DE, Hofman A, Janz OD, Lindhout D. (1997) Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38:981990.
  • Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner AH, Gladstone R, Ashby P, Weksberg R, Einarson T, Koren G. (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271:767770.
  • Vinten J, Bromley RL, Taylor J, Adab N, Kini U, Baker GA. (2009) The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 14:197201.
  • Wide K, Winbladh B, Tomson T, Sars-Zimmer K, Berggren E. (2000) Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: a prospective popuation-based study. Dev Med Child Neurol 42:8792.
  • Wide K, Henning E, Tomson T, Winbladh B. (2002) Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 91:409414.
  • Wide K, Winbladh B, Källén B. (2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93:174176.